Gene therapy for surfactant protein B deficiency using recombinant AAV
Autors principals: | Meyer-Berg, H, Hyde, S, Gill, D |
---|---|
Format: | Conference item |
Publicat: |
Elsevier
2019
|
Ítems similars
-
Gene therapy for surfactant protein B deficiency using recombinant AAV vectors
per: Meyer-Berg, H
Publicat: (2021) -
A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
per: Munis, AM, et al.
Publicat: (2020) -
A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
per: Altar M. Munis, et al.
Publicat: (2021-03-01) -
Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
per: Meyer-Berg, H, et al.
Publicat: (2020) -
Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
per: Helena Meyer-Berg, et al.
Publicat: (2020-10-01)